Pierre-Simon Bellaye

4PUBLICATIONS
13CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 14, 2024
CD40 Agonist on Patient-Derived Xenograft Mice for the Treatment of B-Cell Acute Lymphoblastic Leukemia.

Pierre-Simon Bellaye, Aleksandra Georgievski, Paola Ballerini

|May 20, 2018
Radiolabeled F(ab')2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models.

P-S Bellaye, M Moreau, O Raguin

Pageof 1